http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102167812-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G2650-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L2203-02
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-33396
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-133
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G65-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
filingDate 2010-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102167812-B
titleOfInvention PEGylated cyclopamine analogue and its preparation method and use
abstract The present invention relates to a pegylated cyclopamine analogue, a preparation method and use thereof. Specifically, the present invention relates to a pegylated cyclopamine analog, which is a compound represented by the following formula I, or a compound comprising at least one group moiety represented by the following formula I, each of which is the same or different: Or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, wherein each symbol is as described in the description. The invention also relates to pharmaceutical compositions comprising such compounds, processes for their preparation and their use and methods for the treatment of proliferative diseases.
priorityDate 2010-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466946223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466946224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466401770
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465393789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468123637
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123876783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163645169
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465276479

Total number of triples: 26.